ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Internal Medicine

Top Internal Medicine Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RALPH SAMA MD

Internal Medicine

12,635

$631K

840
737 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $56

JOHN HOWARD M.D.

Internal Medicine

12,610

$884K

439
324 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $56

ERIC KNUTSON MD

Internal Medicine

12,565

$624K

627
507 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $56

TALAL BOU-HARB MD

Internal Medicine

12,555

$632K

566
482 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $56

ALFRED BAUM M.D.

Internal Medicine

12,523

$648K

404
334 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $56

DOUGLAS ONEILL MD

Internal Medicine

12,436

$557K

588
442 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $56

DAVID WEINSTOCK DO

Internal Medicine

12,425

$696K

509
415 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $56

UDAYA JAGADEESAN M.D.

Internal Medicine

12,386

$754K

254
243 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $56

JANET DORAN MD

Internal Medicine

12,353

$565K

651
510 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $56

JEAN SIDDALL-BENSSON M.D.

Internal Medicine

12,342

$589K

401
339 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $56

YOON CHOI MD

Internal Medicine

12,285

$855K

549
371 are 65+

24%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $56

GUIDO NAVARRA M.D.

Internal Medicine

12,264

$847K

652
530 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $56

EDWARD DRISCOLL M.D.

Internal Medicine

12,132

$632K

617
454 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $56

ALAN JACKSON MD

Internal Medicine

12,120

$652K

443
396 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $56

NEVEEN BASSALY M.D.

Internal Medicine

12,112

$641K

443
199 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $56

JAMES MAGUIRE MD

Internal Medicine

12,082

$589K

516
452 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $56

ANDREW POTLER DO

Internal Medicine

12,053

$718K

454
377 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $56

CHI CHEUNG M.D.

Internal Medicine

12,005

$683K

341
254 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $56

MARK SCHRANK MD

Internal Medicine

11,918

$637K

651
569 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $56

JAMES GOTTSCHALL MD

Internal Medicine

11,900

$466K

478
353 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$39
Average prescription price

Avg: $56

MARK HRYNIEWICH MD

Internal Medicine

11,882

$529K

598
514 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $56

JANE THOMPSON M.D.

Internal Medicine

11,856

$528K

591
506 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

2%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $56

LESTER MIETKIEWICZ MD

Internal Medicine

11,806

$525K

552
481 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $56

MICHAEL BURDAY MD

Internal Medicine

11,771

$424K

559
506 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $56

DORINA OMARI M.D.

Internal Medicine

11,734

$8,536

232
203 are 65+

27%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$1
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank